Prosecution Insights
Last updated: November 04, 2026
Application No. 17/526,393

Polarity Reversing Lead

Non-Final OA §102
Filed
Nov 15, 2021
Priority
Jan 28, 2011 — provisional 61/437,561 +6 more
Examiner
WEHRHEIM, LINDSEY GAIL
Art Unit
3799
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Curonix LLC
OA Round
2 (Non-Final)
79%
Grant Probability
Favorable
2-3
OA Rounds
0m
Est. Remaining
98%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allowance Rate
459 granted / 581 resolved
+9.0% vs TC avg
Strong +19% interview lift
Without
With
+19.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
22 currently pending
Career history
615
Total Applications
across all art units

Statute-Specific Performance

§101
3.5%
-36.5% vs TC avg
§103
48.4%
+8.4% vs TC avg
§102
24.6%
-15.4% vs TC avg
§112
18.7%
-21.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 581 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after allowance or after an Office action under Ex Parte Quayle, 25 USPQ 74, 453 O.G. 213 (Comm'r Pat. 1935). Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, prosecution in this application has been reopened pursuant to 37 CFR 1.114. Applicant's submission filed on 7/6/2026 has been entered. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of pre-AIA 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (b) the invention was patented or described in a printed publication in this or a foreign country or in public use or on sale in this country, more than one year prior to the date of application for patent in the United States. Claims 1 and 13 are rejected under pre-AIA 35 U.S.C. 102(b) as being anticipated by Barreras et al (US 5,941,906, hereinafter “Barreras”). Regarding claims 1 and 13, Barreras discloses a circuit for an implantable wirelessly powered device for implantation in a patient's body (col 1, ln 35-52 explaining a prior art neural stimulation system), the circuit comprising: one or more antenna configured to receive at least two input radio-frequency (RF) signals from an external controller through electrical radiative coupling (col 1, ln 35-45, including a neural stimulator system where RF energy is coupled to an implanted receiver), a first input signal of the at least two input RF signals is an RF powering signal (col 1, ln 35-45, the RF transmitter generating a signal to power an implanted neural stimulator) and a second input signal of the at least two RF input signals is an RF telemetry signal that modulates the RF powering signal (col 1, ln 35-52 where the carrier is modulated for a stimulus pulse designating which electrodes are to be used and their polarity, further including an amplitude modulated corresponding to a stimulus width and amplitude); an RF to direct current (DC) rectifying circuit coupled to the one or more antenna on the implantable wirelessly powered device (col 5, ln 60-col 6, ln 5 and col 6, ln 25-64), the rectifying circuit configured to: rectify the RF powering input RF signal received at the one or more antenna (col 5, ln 60-col 6, ln 5; the power received rectified into DC voltage); and convert the RF powering input RF signal to a direct current (DC) power to drive one or more electrodes (col 5, ln 60-col 6, ln 5; the power received rectified into DC voltage); a controller circuit connected to the rectifying circuit and the controller circuit coupled to the one or more electrodes, the controller circuit configured to: generate one or more electrical pulses using the converted DC power (col 6, ln 10-67; where the pulses are generated and delivered from the converted power as in col 5, ln 60-col 6, ln 5); and steer, to each electrode, one or more of the one or more electrical pulses to modulate neural tissue within the patient's body (col 6, ln 10-67; where the pulses are generated and delivered from the converted power as in col 5, ln 60-col 6, ln 5; the invention directed to a neurostimulator similar to the prior art as in col 2, ln 12-67). Allowable Subject Matter Claims 2-12 and 14-16 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Claims 17-20 are allowed. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Lindsey G Wehrheim whose telephone number is (571)270-5181. The examiner can normally be reached Monday - Friday 9 a.m. - 5 p.m. EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Niketa Patel can be reached at (571) 272-4156. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Lindsey G Wehrheim Primary Examiner Art Unit 3799 /LINDSEY G WEHRHEIM/Primary Examiner, Art Unit 3799
Read full office action

Prosecution Timeline

Nov 15, 2021
Application Filed
Apr 10, 2025
Non-Final Rejection mailed — §102
Aug 11, 2025
Response Filed
Jul 06, 2026
Request for Continued Examination
Jul 15, 2026
Response after Non-Final Action
Oct 19, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779200
Percutaneous Circulatory Support Device with Expandable Element
3y 8m to grant Granted Nov 03, 2026
Patent 12779198
Percutaneous Circulatory Support Device with Cannula and Expandable Element
3y 8m to grant Granted Nov 03, 2026
Patent 12773549
CRIMP TOOL FOR COMPRESSIBLE CATHETER PUMP
4y 4m to grant Granted Oct 27, 2026
Patent 12766310
CIRCULATORY SUPPORT DEVICE WITH STEERABLE CANNULA
3y 7m to grant Granted Oct 20, 2026
Patent 12766307
BLOOD PUMP BLOOD COMPATIBILITY DEVICE
3y 7m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
79%
Grant Probability
98%
With Interview (+19.4%)
3y 4m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 581 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month